IBSA Sinovial® HL 64 1x 2.0 ml
For individual advice and exclusive offers.
Flexible payment options:
Credit card, SEPA, purchase on account (for clinics & practices), Klarna, PayPal and much more
IBSA Sinovial® HL 64 1x 2.0 ml
IBSA Sinovial® HL 64 1x 2.0 ml is a high quality one Hyaluronic acid joint injection for intra-articular treatment of Osteoarthritis in large and medium joints. The viscoelastic solution with high molecular weight hyaluronic acid (64 mg) offers long-lasting pain relief and improved joint function – developed by IBSA with pharmaceutical expertise and innovative technology.
Product features IBSA Sinovial® HL 64
- Active ingredient: 32 mg/ml sodium hyaluronate (64 mg per 2.0 ml pre-filled syringe)
- High molecular weight hyaluronic acid: Optimal viscosity for maximum joint protection
- High concentration: 64 mg for intensive and long-lasting effects
- Sterile & pyrogen-free: CE certified according to the highest medical device standards
- IBSA quality: Swiss pharmaceutical company with international expertise
- Pre-filled syringe: Ready to use for direct intra-articular use
- Clinically proven: Many years of experience in osteoarthritis therapy
Areas of application
IBSA Sinovial® HL 64 is used for the symptomatic treatment of Osteoarthritis used in large and medium joints. Particularly suitable for:
- Knee joint arthrosis (gonarthrosis)
- Hip joint arthrosis (coxarthrosis)
- Shoulder joint arthrosis
- Patients with chronic joint pain
- Restriction of movement due to joint wear
- People who do not want to tolerate NSAIDs
Mechanism of action
Hyaluronic acid is a natural component of the synovial fluid. IBSA Sinovial® HL 64 works through:
- Improving viscosity: Increases elasticity of the synovial fluid
- Shock absorber function: Protects cartilage from mechanical stress
- Lubrication: Reduces friction for more pain-free movement
- Cartilage protection: Protects cartilage tissue from further wear and tear
- Anti-inflammatory: Supports the reduction of joint inflammation
Application & dosage
Dosage: 1 injection of 2.0 ml into the affected joint
Treatment regimen: Single injection or weekly injections for 3-5 weeks (depending on doctor's recommendation)
Repeat: Repeatable after 6-12 months if necessary
Administration: Intra-articularly by a healthcare professional
Scope of delivery
- 1 sterile pre-filled syringe with 2.0 ml IBSA Sinovial® HL (64 mg hyaluronic acid)
- Instructions for use
- CE declaration of conformity
Storage
Store at room temperature (max. 25°C). Do not freeze. Protect from light. Note expiry date.
Manufacturer
IBSA Institut Biochimique SA – Swiss pharmaceutical company with international expertise in the development of high-quality medical products and viscoelastic solutions for joint therapy.
This product is intended for use by healthcare professionals only. Please note the instructions for use and specialist information.
- Manufacturer IBSA Institut Biochimique SA